Preliminary clinical safety and activity of MK-3475 monotherapy for the treatment of previously treated patients with non-small cell lung cancer (NSCLC) Meeting Abstract
| Authors: | Garon, E. B.; Balmanoukian, A.; Hamid, O.; Hui, R. N.; Gandhi, L.; Leighl, N.; Gubens, M. A.; Goldman, J.; Lubiniecki, G. M.; Lunceford, J.; Gergich, K.; Rizvi, N. |
| Abstract Title: | Preliminary clinical safety and activity of MK-3475 monotherapy for the treatment of previously treated patients with non-small cell lung cancer (NSCLC) |
| Meeting Title: | 15th World Conference on Lung Cancer (IASLC) |
| Keywords: | pd-1; pd-l1; lambrolizumab |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 8 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2013 Oct 27-31 |
| Meeting Location: | Sydney, Australia |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2013-11-01 |
| Start Page: | S364 |
| End Page: | S365 |
| Language: | English |
| ACCESSION: | WOS:000339624901244 |
| PROVIDER: | wos |
| DOI: | 10.1097/01.JTO.0000438438.14562.c8 |
| Notes: | Meeting Abstract: MO18.02 -- Source: Wos |
